Morelatto R, Itoiz ME, Guiñazú N, Piccini D, Gea S, López-de Blanc S. Nitric oxide synthase 2 (NOS2) expression in histologically normal margins of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2014 May 1;19 (3):e242-7.

doi:10.4317/medoral.19351

http://dx.doi.org/doi:10.4317/medoral.19351

1. Hollows P, Mc Andrew PG, Pierini MG. Delays in the referral and treatment of oral squamous cell carcinoma. Br Dent J. 2000;188:262-5.

2. Jones AS, Beasley N, Houghton D, Husband DJ. The effects of stage on survival and other parameters in squamous cell carcinoma of the oral cavity, pharynx and larynx. Clin Otolaryngol Allied Sci. 1998;23:51-6.
http://dx.doi.org/10.1046/j.1365-2273.1998.00086.x

3. Morelatto RA, López de Blanc SA. Oral cancer mortality in the province of Cordoba, Argentine Republic in the period 1975-2000. A comparative study with other populations. Med Oral Patol Oral Cir Bucal. 2006;11:e230-5.

4. La Vecchia C, Lucchini F, Negri E, Levi F. Trends in oral cancer mortality in Europe. Oral Oncol. 2004;40:433-9.
http://dx.doi.org/10.1016/j.oraloncology.2003.09.013

5. Macfarlane GJ, Evstifeeva TV, Robertson C, Boyle P, Scully C. Trends of oral cancer mortality among females worldwide. Cancer Causes Control. 1994;5:255-8.
http://dx.doi.org/10.1007/BF01830245

6. Boyle P, Leon ME, Maisonneuve P, Autier P. Cancer control in women. Update 2003. Int J Gynaecol Obstet. 2003;83 Suppl 1:179-202.
http://dx.doi.org/10.1016/S0020-7292(03)90121-4

7. Morelatto RA, Herrera MC, Fernández EN, Corball AG, López de Blanc SA. Diagnostic delay of oral squamous cell carcinoma in two diagnosis centers in Cordoba, Argentina. J Oral Pathol Med. 2007;36:405-8.
http://dx.doi.org/10.1111/j.1600-0714.2007.00547.x

8. Lessa RC, Campos AH, de Freitas CE, da Silva FR, Kowalski LP, Carvalho AL, et al. Identification of upregulated genes in oral squamous cell carcinomas. Head Neck. 2013;35:1475-81.

9. Slaughter DP, Southwick hw, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6:963-8.
http://dx.doi.org/10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q

10. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YS, et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med. 1995;332:712-7.
http://dx.doi.org/10.1056/NEJM199503163321104

11. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63:1727-30.

12. Tabor M, Brakenhoff H, Ruijter-Schippers H, Van Der Wal J, Snow G, Leemans C, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res. 2001;7:1523-32.

13. Schwint AE, Savino TM, Lanfranchi HE, Marschoff E, Cabrini RL, Itoiz ME. Nucleolar organizer regions in lining epithelium adjacent to squamous cell carcinoma of human oral mucosa. Cancer. 1994;73:2674-9.
http://dx.doi.org/10.1002/1097-0142(19940601)73:11<2674::AID-CNCR2820731104>3.0.CO;2-4

14. Chimeno Zoth SA, Collet AM, Heber E, Schwint AE, Itoiz ME. Early detection of alterations associated to oral cancer. Acta Odontol Latinoam. 2000;13:100-12.

15. López de Blanc SA, Collet AM , Gandolfo MS, Femopase F, Hernández SL, Tomasi VH, et al. Nucleolar organizer regions (AgNOR) and subepitelial vascularization as field cancerization markers in oral mucosa biopsies of alcoholic and smoking patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:747-53.
http://dx.doi.org/10.1016/j.tripleo.2009.06.028

16. Gandolfo M, Keszler A, Lanfranchi H, Itoiz ME. Increased subepithelial vascularization and VEGF expression reveal potentially malignant changes in human oral mucosa lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:486-93.
http://dx.doi.org/10.1016/j.tripleo.2010.11.018

17. Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 2007;67:1407-1410.
http://dx.doi.org/10.1158/0008-5472.CAN-06-2149

18. Shang ZJ, Li JR, Li ZB. Effects of exogenous nitric oxide on oral squamous cell carcinoma: an in vitro study. J Oral Maxillofac Surg. 2002;60:905-10.
http://dx.doi.org/10.1053/joms.2002.33860

19. Lyons CR. The role of nitric oxide in inflammation. Adv Immunol. 1995;60:323-71.
http://dx.doi.org/10.1016/S0065-2776(08)60589-1

20. Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and Cancer: a review. World Journal of Surgical Oncology. 2013;11:118.
http://dx.doi.org/10.1186/1477-7819-11-118

21. Brennan PA, Umar T, Zaki GA, Langdo JD, Spedding AV, Buckley J, et al. Are myoephitelial cells responsible for the widespread expression of inducible nitric oxide synthase in pleomorphic adenoma? An immunohistochemical study. J Oral Pathol Med. 2000;29:279-83.
http://dx.doi.org/10.1034/j.1600-0714.2000.290607.x

22. Chen YK, Hsuen SS, Lin LM. Expression of inducible nitric oxide synthase in human oral premalignant epithelial lesions. Arch Oral Biol. 2002;47:387-92.
http://dx.doi.org/10.1016/S0003-9969(02)00011-0

23. Ou Yang KX, Liang J, Huang ZQ. Association of clinicopathologic parameters with the expression of inducible nitric oxide synthase and vascular endothelial growth factor in mucoepidermoid carcinoma. Oral Dis. 2011;17:590-6.
http://dx.doi.org/10.1111/j.1601-0825.2011.01813.x

24. Brennan PA, Palacios-Callender M, Zaki GA, Spedding AV, Langdon JD. Type II nitric oxide synthase (NOS2) expression correlates with lymph node status in oral squamous cell carcinoma. J Oral Pathol Med. 2001;30:129-34.
http://dx.doi.org/10.1034/j.1600-0714.2001.300301.x

25. Brennan PA, Conroy B, Sinclair D, Spedding A. Expression of inducible nitric oxide synthase and p53 in oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 90:624-9.
http://dx.doi.org/10.1067/moe.2000.108800

26. Connelly S, Macabeo-Ong M, Dekker N, Jordan R, Schmidt B. Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol. 2005;41:261-7.
http://dx.doi.org/10.1016/j.oraloncology.2004.09.007

27. Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS. Role of nitric oxide and antioxidant enzymes in the pathogenesis of oral cancer. JCRT. 2009;5:247-253.
http://dx.doi.org/10.4103/0973-1482.59898

28. Grammatica L, Piepoli S, D'Auria C, Achille G, Marzullo F, Zito FA, et al. Primary tumours neoangiogenesis and P53 expression in oral carcinoma patients. J Exp Clin Cancer Res. 2001;20:225-30.

29. Brouha X, Tromp D, Hordijk GJ, Winnubst J, De Leeuw R. Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol. 2005;125:552-6.

30. Zanetti R, Rosso S, Martinez C, Navarro C, Schraub S, Sancho Garnier H, et al. The multicentre south European study 'Helios'. I: skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73:1440-6.
http://dx.doi.org/10.1038/bjc.1996.274

31. Pentenero M, Broccoletti R, Carbone M, Corotto D, Gandolfo S. The prevalence of oral mucosal lesions in adults from the Turin area. Oral Dis. 2008;4:356-366.
http://dx.doi.org/10.1111/j.1601-0825.2007.01391.x

32. Chen YK, Hsue SS, Lin LM. Increased expression of inducible nitric oxide synthase or human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies. Head Neck. 2002; 24:925-32.
http://dx.doi.org/10.1002/hed.10131

33. Chen YK, Lin LM. Immunohistochemical expression of inducible nitric oxide synthase in DMBA-induced hamster buccal pouch carcinogenesis. Oral Oncol. 2000;36:221-4.
http://dx.doi.org/10.1016/S1368-8375(99)00081-0

34. Chen WL, Zeng SG, Li HG, Huang HZ, Pan CB. Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue. Ai Zheng. 2002;21:314-8.

35. Grimm E, Ellerhorst J, Tang Chi-Hui, Ekmekcioglu S. Constitutive intracellular production of iNOS and NO in human melanoma:possible role in regulation of growth and resistance to apoptosis. Nitric oxide. 2008;9:133-7.
http://dx.doi.org/10.1016/j.niox.2008.04.009

36. Ekmekcioglu S, Ellerhorst J, Smid C, Prieto V, Munsell M, Buzaid A, et al Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res. 2000;6:4768-75.

37. Brennan P, Tijjani U, Wilson A, Mellor T. Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia. J Oral Maxillofac Surg. 2002;60:1455-60.
http://dx.doi.org/10.1053/joms.2002.36122

38. Harada K, Supriatno, Kawaguchi S, Tomitaro O, Yoshida H, Sato M. Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. In Vivo. 2004;18:449-55.

39. Aggarwal B, Shishodia S, Sandur S, Pandey M, Sethi G. Inflammation and cancer: How hot is the link? Biochem Pharmacol. 2006;72:1605-21.
http://dx.doi.org/10.1016/j.bcp.2006.06.029

40. Fitzpatrick B, Mehibel M, Cowen RL, Stratford IJ. iNOS as a therapeutic target for treatment of human tumors. Nitric Oxide. 2008;19:217-24.
http://dx.doi.org/10.1016/j.niox.2008.05.001